Development and validation of a thallium flux-based functional assay for the sodium channel NaV1.7 and its utility for lead discovery and compound profiling.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  ACS Chemical Neuroscience

• Publication date

  2015-04-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschemneuro.5b00004PMID 25879403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation and Optimization of Novel High-Throughput Assays for Human Epithelial Sodium Channels

  2015cited by this paper
• Mechanisms underlying the activation of G-protein–gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297

  2014cited by this paper
• Discovery of potent and selective GIRK1/2 modulators via 'molecular switches' within a series of 1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)ureas.

  2014cited by this paper
• Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.

  2013cited by this paper
• High-throughput fluorescent-based NKCC functional assay in adherent epithelial cells

  2013cited by this paper
• Neuroactive insecticides: targets, selectivity, resistance, and secondary effects.

  2013cited by this paper
• Ion channels as therapeutic targets: a drug discovery perspective.

  2013cited by this paper
• Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors.

  2013cited by this paper
• ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.

  2013cited by this paper
• Identification and Characterization of a Compound That Protects Cardiac Tissue from Human Ether-à-go-go-related Gene (hERG)-related Drug-induced Arrhythmias*

  2012cited by this paper
• Ion channel drug discovery: challenges and future directions.

  2012cited by this paper
• Advances in the mode of action of pyrethroids.

  2012cited by this paper
• Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel

  2011cited by this paper
• Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy.

  2011cited by this paper
• Curious about pesticide action.

  2011cited by this paper
• Discovery, Characterization, and Structure–Activity Relationships of an Inhibitor of Inward Rectifier Potassium (Kir) Channels with Preference for Kir2.3, Kir3.X, and Kir7.1

  2011cited by this paper
• Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.

  2011cited by this paper
• Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay.

  2011cited by this paper
• Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener.

  2011cited by this paper
• Targeting ion channels for drug discovery.

  2010cited by this paper
• Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability

  2010cited by this paper
• Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.

  2010cited by this paper
• Familial pain syndromes from mutations of the Nav1.7 sodium channel

  2010cited by this paper
• Identification and Characterization of Novel NMDA Receptor Antagonists Selective for NR2A- over NR2B-Containing Receptors

  2010cited by this paper
• A Pharmacologically Validated, High-Capacity, Functional Thallium Flux Assay for the Human Ether-à-go-go Related Gene Potassium Channel

  2010cited by this paper
• Targeting voltage-gated sodium channels for pain therapy

  2010cited by this paper
• Screening technologies for ion channel drug discovery.

  2010cited by this paper
• Evolution of the human ion channel set.

  2009cited by this paper
• High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1

  2009cited by this paper
• Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2

  2009cited by this paper
• High throughput screening assay of alpha(1G) T-type Ca2+ channels and comparison with patch-clamp studies.

  2009cited by this paper
• A novel Nav1.7 mutation producing carbamazepine‐responsive erythromelalgia

  2009cited by this paper
• Sodium channel inhibitor drug discovery using automated high throughput electrophysiology platforms.

  2009cited by this paper
• High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology

  2008cited by this paper
• Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine

  2008cited by this paper
• A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors

  2008cited by this paper
• Validation of High Throughput Screening Assays Against Three Subtypes of Cav3 T-Type Channels Using Molecular and Pharmacologic Approaches

  2007cited by this paper
• Automated ion channel screening: patch clamping made easy

  2007cited by this paper
• Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations

  2007cited by this paper
• A Nonadherent Cell-Based HTS Assay for N-Type Calcium Channel Using Calcium 3 Dye

  2006cited by this paper
• Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine

  2004cited by this paper
• Functional Assay of Voltage-Gated Sodium Channels Using Membrane Potential-Sensitive Dyes

  2004cited by this paper
• A Thallium-Sensitive, Fluorescence-Based Assay for Detecting and Characterizing Potassium Channel Modulators in Mammalian Cells

  2004cited by this paper
• State-dependent mibefradil block of Na+ channels.

  2004cited by this paper
• Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR.

  2004cited by this paper
• Stable expression and characterization of human PN1 and PN3 sodium channels.

  2003cited by this paper
• Stereoselectivity of bupivacaine in local anesthetic-sensitive ion channels of peripheral nerve.

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Effects of veratridine on sodium currents and fluxes.

  1998cited by this paper
• The Permeability of the Sodium Channel to Metal Cations in Myelinated Nerve

  1972cited by this paper

• Discovery of Nav1.7 Inhibitors through the Screening of Marine Natural Product Extracts

  2025cites this paper
• Atypical KCNQ1/Kv7 channel function in a neonatal diabetes patient: Hypersecretion preceded the failure of pancreatic β-cells

  2024cites this paper
• ION Thallos-HTL: a fluorescent thallium indicator that enables cell-selective and localizable thallium flux assays.

  2024cites this paper
• CL-705G: a novel chemical Kir6.2-specific KATP channel opener

  2023cites this paper
• Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells

  2022cites this paper
• Toward Quantitative Models in Safety Assessment: A Case Study to Show Impact of Dose–Response Inference on hERG Inhibition Models

  2022cites this paper
• Inhibition of NaV1.7: the possibility of ideal analgesics.

  2022cites this paper
• Screening an In-House Isoquinoline Alkaloids Library for New Blockers of Voltage-Gated Na+ Channels Using Voltage Sensor Fluorescent Probes: Hits and Biases

  2022cites this paper
• Ten-Year Retrospective of the Vanderbilt Institute of Chemical Biology Chemical Synthesis Core.

  2021cites this paper
• Deep Mutational Scan of an SCN5A Voltage Sensor

  2020cites this paper
• Correlation of Optical and Automated Patch Clamp Electrophysiology for Identification of NaV1.7 Inhibitors

  2020cites this paper
• VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons.

  2020cites this paper
• Emerging neurotechnology for antinoceptive mechanisms and therapeutics discovery.

  2019cites this paper
• Deep Mutational Scan of a cardiac sodium channel voltage sensor

  2019cites this paper
• Purification and biochemical characterisation of a putative sodium channel agonist secreted from the South African Knobbly sea anemone Bunodosoma capense.

  2019cites this paper
• A high-throughput Ca2+ flux assay to monitor cyclic nucleotide-gated channel activity and characterize achromatopsia mutant channel function.

  2019cites this paper
• Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels.

  2018cites this paper
• A Thallium-Based Screening Procedure to Identify Molecules That Modulate the Activity of Ca2+-Activated Monovalent Cation-Selective Channels

  2018cites this paper
• Prediction of hERG Liability – Using SVM Classification, Bootstrapping and Jackknifing

  2017cites this paper
• Reply to The small molecule CLP257 does not modify activity of the K+–Cl− co-transporter KCC2 but does potentiate GABAA receptor activity

  2017cites this paper
• Optogenetic Approaches to Drug Discovery in Neuroscience and Beyond.

  2017cites this paper
• Functional Studies of Sodium Channels: From Target to Compound Identification

  2016cites this paper
• Contribution of Automated Technologies to Ion Channel Drug Discovery.

  2016cites this paper
• High throughput screening technologies for ion channels

  2015cites this paper